AIM: To determine the expression of L1 in pancreatic neuroendocrine tumor and to correlate it with WHO classification of this tumor. METHODS: We retrospectively analyzed L1 expression in 63 cases of pancreatic neuroendocrine tumor by immunohistochemistry on paraffin sections of primary tumors or metastases. Staining was performed by peroxidase technique with monoclonal antibody UJ127.11 against human L1. All tumors were classified according to WHO classification as well-differentiated neuroendocrine tumors and carcinomas or poorly-differentiated neuroendocrine carcinomas. RESULTS: L1 was detected in 5 (7.9%) of 63 pancreatic neuroendocrine tumors. Four (44.4%) of 9 poorly-differentiated carcinomas expressed L1. In contrast, only 1 (1.9%) of 54 well-differentiated tumors or carcinomas was positive for L1. No expression was found in Langerhans islet cells of normal pancreatic tissue. Cross table analysis showed a significant association between L1 expression and classification of neuroendocrine tumors of the pancreas (P<0.01). CONCLUSION: L1 is specifically expressed in poorly-differentiated pancreatic neuroendocrine carcinomas that are known to have the worst prognosis. L1 might be a marker for risk prediction of patients diagnosed with pancreatic neuroendocrine carcinomas.
AIM: To determine the expression of L1 in pancreatic neuroendocrine tumor and to correlate it with WHO classification of this tumor. METHODS: We retrospectively analyzed L1 expression in 63 cases of pancreatic neuroendocrine tumor by immunohistochemistry on paraffin sections of primary tumors or metastases. Staining was performed by peroxidase technique with monoclonal antibody UJ127.11 against human L1. All tumors were classified according to WHO classification as well-differentiated neuroendocrine tumors and carcinomas or poorly-differentiated neuroendocrine carcinomas. RESULTS: L1 was detected in 5 (7.9%) of 63 pancreatic neuroendocrine tumors. Four (44.4%) of 9 poorly-differentiated carcinomas expressed L1. In contrast, only 1 (1.9%) of 54 well-differentiated tumors or carcinomas was positive for L1. No expression was found in Langerhans islet cells of normal pancreatic tissue. Cross table analysis showed a significant association between L1 expression and classification of neuroendocrine tumors of the pancreas (P<0.01). CONCLUSION: L1 is specifically expressed in poorly-differentiated pancreatic neuroendocrine carcinomas that are known to have the worst prognosis. L1 might be a marker for risk prediction of patients diagnosed with pancreatic neuroendocrine carcinomas.
Authors: M F Heymann; M Joubert; J Nemeth; B Franc; J Visset; A Hamy; J le Borgne; J C le Neel; A Murat; S Cordel; M F le Bodic Journal: Histopathology Date: 2000-05 Impact factor: 5.087
Authors: Anka Thies; Melitta Schachner; Ingrid Moll; Jürgen Berger; Hans-Joachim Schulze; Georg Brunner; Udo Schumacher Journal: Eur J Cancer Date: 2002-09 Impact factor: 9.162
Authors: E Kettunen; A G Nicholson; B Nagy; H Wikman; J K Seppänen; T Stjernvall; T Ollikainen; V Kinnula; S Nordling; J Hollmén; S Anttila; S Knuutila Journal: Carcinogenesis Date: 2004-09-24 Impact factor: 4.944
Authors: Mina Fogel; Sabine Mechtersheimer; Monica Huszar; Asya Smirnov; Adel Abu-Dahi; Wolfgang Tilgen; Jörg Reichrath; Thomas Georg; Peter Altevogt; Paul Gutwein Journal: Cancer Lett Date: 2003-01-28 Impact factor: 8.679
Authors: S Mechtersheimer; P Gutwein; N Agmon-Levin; A Stoeck; M Oleszewski; S Riedle; R Postina; F Fahrenholz; M Fogel; V Lemmon; P Altevogt Journal: J Cell Biol Date: 2001-11-12 Impact factor: 10.539
Authors: Frank Bergmann; Sebastian Aulmann; Bence Sipos; Matthias Kloor; Anja von Heydebreck; Johannes Schweipert; Andreas Harjung; Philipp Mayer; Werner Hartwig; Gerhard Moldenhauer; David Capper; Gerhard Dyckhoff; Kolja Freier; Esther Herpel; Anja Schleider; Peter Schirmacher; Gunhild Mechtersheimer; Günter Klöppel; Hendrik Bläker Journal: Virchows Arch Date: 2014-10-09 Impact factor: 4.064
Authors: Emma Elizabeth Ilett; Seppo W Langer; Ingrid Holst Olsen; Birgitte Federspiel; Andreas Kjær; Ulrich Knigge Journal: Diagnostics (Basel) Date: 2015-04-08
Authors: Hao Hong; Christine E Brown; Julie R Ostberg; Saul J Priceman; Wen-Chung Chang; Lihong Weng; Paul Lin; Mark T Wakabayashi; Michael C Jensen; Stephen J Forman Journal: PLoS One Date: 2016-01-13 Impact factor: 3.240
Authors: Donatella Delle Cave; Martina Di Guida; Valerio Costa; Marta Sevillano; Luigi Ferrante; Christopher Heeschen; Marco Corona; Antonio Cucciardi; Enza Lonardo Journal: Oncogene Date: 2020-04-14 Impact factor: 9.867